| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.09 | 0.05 |